Brief: Genprex Strengthens Diabetes Gene Therapy Program With License Of Additional Tech

Genprex

15/12/2022 14:14

Dec 15 (Reuters) - Genprex Inc  GNPX.O :
    * GENPREX STRENGTHENS DIABETES GENE THERAPY PROGRAM WITH
LICENSE
OF ADDITIONAL TECHNOLOGY FROM UNIVERSITY OF PITTSBURGH

Source text for Eikon:  ID:nPn4CVTbFa 
Further company coverage:  GNPX.O 
 ((Reuters.Briefs@thomsonreuters.com;))